Prescription RequiredCrizalk 250mg Capsule contains Crizotinib, a targeted cancer therapy used to treat patients with non-small cell lung cancer (NSCLC) that is positive for ALK (anaplastic lymphoma kinase) or ROS1 gene rearrangements.
| Generic Name | Crizotinib |
| Manufacturer | Pfizer Ltd |
| Packing | 60 Capsules |
| Prescribed For | Lung Cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.
